End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | +28.13% | +34.75% | +51.85% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | - | - | 26.13 |
Enterprise Value (EV) 1 | - | - | 31.19 |
P/E ratio | -51.4 x | -7.25 x | -0.82 x |
Yield | - | - | - |
Capitalization / Revenue | - | - | 25.6 x |
EV / Revenue | - | - | 30.5 x |
EV / EBITDA | - | - | -3.74 x |
EV / FCF | - | - | 1,078,109 x |
FCF Yield | - | - | 0% |
Price to Book | -26.5 x | -7.41 x | -1.48 x |
Nbr of stocks (in thousands) | - | - | 32,263 |
Reference price 2 | 10.10 | 10.44 | 0.8100 |
Announcement Date | 7/22/22 | 4/11/23 | 4/9/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 0.824 | 1.092 | 1.153 | 1.022 |
EBITDA 1 | -2.918 | -2.696 | -6.091 | -8.346 |
EBIT 1 | -2.932 | -2.711 | -6.116 | -8.374 |
Operating Margin | -355.83% | -248.27% | -530.58% | -819.68% |
Earnings before Tax (EBT) 1 | -2.822 | -2.941 | -6.566 | -23.21 |
Net income 1 | -2.822 | -2.941 | -6.566 | -23.21 |
Net margin | -342.41% | -269.37% | -569.63% | -2,271.37% |
EPS | - | -0.1966 | -1.440 | -0.9844 |
Free Cash Flow | - | -0.7497 | -3.477 | 28.93 |
FCF margin | - | -68.67% | -301.65% | 2,831.5% |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 7/22/22 | 7/22/22 | 4/11/23 | 4/9/24 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 2.52 | 4.2 | 9.76 | 5.05 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | -0.8627 x | -1.557 x | -1.603 x | -0.6056 x |
Free Cash Flow | - | -0.75 | -3.48 | 28.9 |
ROE (net income / shareholders' equity) | - | 68.7% | 80.2% | 1,294% |
ROA (Net income/ Total Assets) | - | -280% | -339% | -33.9% |
Assets 1 | - | 1.051 | 1.939 | 68.49 |
Book Value Per Share | - | -0.3800 | -1.410 | -0.5500 |
Cash Flow per Share | - | 0.0500 | 0.0400 | 0 |
Capex | - | 0.03 | 0.06 | 0.04 |
Capex / Sales | - | 2.74% | 5.04% | 4.28% |
Announcement Date | 7/22/22 | 7/22/22 | 4/11/23 | 4/9/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+51.85% | 26.24M | |
+24.75% | 4.78B | |
-14.49% | 2.55B | |
+55.35% | 2.43B | |
+17.53% | 1.84B | |
-14.12% | 1.39B | |
-28.28% | 1.36B | |
-32.08% | 1.2B | |
-15.65% | 1.06B | |
+118.67% | 692M |
- Stock Market
- Equities
- ONMD Stock
- Financials OneMedNet Corporation